Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

Global Urea Breath Test Market, by Test Type (Point-of-Care Tests (POCT) and Laboratory Based Test), by Product (Breath Analyzer and UBT- Kits), by Method (Mass Spectrometer, Infrared Spectrometer, and Laser Assisted Rationalizer), by End User (Hospitals, Clinics, and Diagnostic Centers (Standalone Labs and Private Lab Networks)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 110.7 million in 2021, and is expected to exhibit a CAGR of 5.1% during the forecast period (2021-2028).

Market players and healthcare organizations are involved in research and development activities and spreading awareness about digestive diseases, which is expected to spur the growth of the global urea breath test market over the forecast period.

For instance, in December 2019, The Council of the Asian Pacific Association of Gastroenterology conducted an Asian Pacific Digestive Week (APDW). The initiative was focused on expanding the understanding of gastroenterology and hepatology in Asia Pacific region.

Global Urea Breath Test Market - Impact of Coronavirus (COVID – 19) Pandemic

COVID-19 outbreak was first reported on December 31, 2019, in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 211.2 million cases and 4.4 million deaths have been reported due to Coronavirus (COVID-19) up till August 22, 2021, across the globe.

The COVID-19 pandemic has affected several markets across the globe and is also expected to hamper the global urea breath test market. The COVID-19 pandemic has affected the demand and supply of healthcare products in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and due to its financial impact on firms and financial markets. Several ophthalmology surgeries are currently at halt due to COVID-19 crisis in order to ensure safety of the patients. Supply chain and manufacturing activities in India, China, the U.S., and others have been disrupted due to lockdowns. Whereas, the countries such as Thailand, Indonesia, Singapore, and others are facing problems with transportation of raw materials.

Browse 148 Market Data Tables and 34 Figures spread through 319 Pages and in-depth TOC on Global Urea Breath Test Market, by Test Type (Point-of-Care Tests (POCT) and Laboratory Based Test), by Product (Breath Analyzer and UBT- Kits), by Method (Mass Spectrometer, Infrared Spectrometer, and Laser Assisted Rationalizer), by End User (Hospitals, Clinics, and Diagnostic Centers (Standalone Labs and Private Lab Networks)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the global urea breath test market, click the link below:

 https://www.coherentmarketinsights.com/market-insight/urea-breath-test-market-4645

Increasing studies focused on urea breath test over histopathogical test for H. Pylori Detection is anticipated to boost the market growth over the forecast period. For instance, in June 2021, a research study was published in Dove Press Ltd. which compared diagnostic value for 14C urea breath test in comparison to histopathology in Indonesian dyspeptic patients. The paper highlighted the fact that there is very limited number of hospitals with endoscopy system in Indonesia. Hence, alternative non-invasive methods such as urea breath test will be favorable alternative for covering Indonesian populations for diagnosing H. pylori.

Key Takeaways of the Global Urea Breath Test Market:

  • The global urea breath test market is expected to exhibit a CAGR of 5.1% over the forecast period (2021-2028). North America is expected to account for major market share over the forecast period (2021-2028) owing rising number of product launches. For instance, in August 2017, Exalenz Bioscience expanded its BreathID Hp urea breath testing product line by the introduction of the BreathID Hp Lab system in San Diego, U.S. The new system is time-efficient solution which is used for detecting active H. pylori bacterium infection. Hence, the new BreathID Hp Lab system having 99% specificity and sensitivity for H. pylori detection will propel the market growth.
  • Some of the major players operating in the global urea breath test market include Mayoli Spindler (Kibion AB), Otsuka Pharmaceutical Co. Ltd., Sercon Group, Meridian Bioscience, Paladin Labs Inc., Beijing Richen- Force Science & Technology Co., Ltd., Fisher Analysen Methode GmbH (FAN), Avanos Medical, Inc., Beijing Binal Health Bio-Sci & Tech Co., Ltd, Kizlon Medical, and Gulf Coast Scientific, Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.